US Stock Market Move | Moderna (MRNA.US) plans to issue $2 billion in convertible senior notes, and its stock has dropped over 5%.
On Thursday, Moderna (MRNA.US) opened lower and continued to decline. As of the time of this report, it had fallen more than 5%, with a market value of approximately $56.6 billion.
On Thursday, Moderna (MRNA.US) opened lower and continued to decline, with a drop of over 5% as of the time of publication, bringing its market value to approximately $56.6 billion. In terms of news, Moderna will issue $2 billion worth of convertible senior notes. Previously, Moderna and Merck & Co., Inc. jointly announced that their individualized cancer vaccine intismeran in combination with Keytruda (pembrolizumab) achieved both of the primary endpointsrecurrence-free survival (RFS) and distant metastasis-free survival (DMFS)in the Phase III trial INTerpath-001 for completely resected stage IIB to IV melanoma. Over the past week, the stock has recorded an increase of nearly 130%.
Related Articles
CGN MINING (01164) announced its interim results, reporting a loss attributable to owners of approximately HKD 80 million, an increase of 18% year-on-year.
SHENZHEN INVEST (00604): Wang Yuwen appointed as Chairman of the Sustainability Committee
MEDBOT-B(02252): Establishment of the ESG Committee
CGN MINING (01164) announced its interim results, reporting a loss attributable to owners of approximately HKD 80 million, an increase of 18% year-on-year.
SHENZHEN INVEST (00604): Wang Yuwen appointed as Chairman of the Sustainability Committee
MEDBOT-B(02252): Establishment of the ESG Committee
RECOMMEND
